病毒性肝炎诱导的HCC中的免疫疗法反应:系统性审查和元分析
Junaid Anwar1, Hafiz Muhammad Arslan2, Zouina Sarfraz3
1Department of Medicine, Baptist Hospitals of Southeast Texas, Beaumont, TX 77701, USA.
Current oncology (Toronto, Ont.)
|November 26, 2024
概括
免疫疗法为肝细胞癌 (HCC) 提供了改善的结果,特别是在与病毒性肝炎相关的病例中. 与非病毒性HCC患者相比,病毒性HCC患者的无进展和整体存活率显著改善.
科学领域:
- 在瘤学瘤学.
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因,经常与乙型肝炎 (HBV) 和C型肝炎 (HCV) 病毒感染有关.
- 现有的HCC治疗方法往往会产生低于最佳的预后,这强调了对新型治疗策略的需求.
- 免疫疗法已成为治疗各种癌症的有希望的方法,包括HCC.
研究的目的:
- 评估免疫治疗治疗肝细胞癌 (HCC) 的疗效.
- 专门评估与病毒性肝炎相关的HCC病例的治疗结果.
- 为了比较免疫治疗在病毒性与非病毒性HCC中的有效性.
主要方法:
- 一个符合PRISMA声明2020指南的元分析.
- 包括公布至2024年4月的随机对照试验.
- 使用固定效应模型分析客观反应率 (ORR),无进展生存率 (PFS) 和整体生存率 (OS).
主要成果:
- 包括9项试验,5316名患者;病毒性HCC显示出非显著的ORR较高的趋势.
- 病毒性HCC患者的无进展生存时间中位数显著改善 (7.3个月对5.8个月,p=0.005).
- 病毒性HCC患者的平均整体存活时间明显长 (16.8个月与15.2个月,p<0.0001),HBV相关的HCC显示出更好的生存趋势.
结论:
- 免疫疗法在治疗肝细胞癌 (HCC) 中表现出显著的疗效,特别是在B型病毒性肝炎 (HBV) 或C型病毒性肝炎 (HCV) 感染的患者中.
- 与病毒性肝炎相关的肝细胞癌显示,与非病毒性病因相比,免疫治疗的生存结果优越.
- 考虑到HCC病毒病因学的个性化治疗策略对于优化免疫治疗结果至关重要.
关键词:
癌症治疗 治疗 治疗 癌症临床试验是指临床试验中的临床试验.乙型肝炎 B 型肝炎型肝炎C型肝炎的发生肝细胞癌是肝细胞癌.免疫疗法 免疫疗法客观的响应是客观的响应.个性化医疗是个性化的医疗.幸存率 幸存率 生存率更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.1K
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
2.9K
相关概念视频
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Immune Response Against Viral Pathogens
751
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
751
Cytotoxic T Cells-mediated Immune Response
849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
